Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy R1 RCM stock in Canada | $23.15
Own R1 RCM shares in just a few minutes.
R1 RCM is a health information services business based in the US. R1 RCM stocks (RCM.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $22.3 – a decrease of 8.89% over the previous week. R1 RCM employs 19,000 staff and has a trailing 12-month revenue of around $1.3 billion.
How to buy R1 RCM stock in Canada
- Choose a platform. If you're a beginner, our stock trading table below can help you choose.
- Open your account. You'll need your ID, bank details and national insurance number.
- Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
- Search the platform for stock code: RCM in this case.
- Research R1 RCM stocks. The platform should provide the latest information available.
- Buy your R1 RCM stocks. It's that simple.
What's in this guide?
- Can I buy shares in R1 RCM?
- Has coronavirus impacted R1 RCM shares?
- R1 RCM shares summary
- Compare share dealing platforms
- Is R1 RCM stock a buy or sell?
- R1 RCM performance over time
- Can I short R1 RCM shares?
- Are R1 RCM shares over-valued?
- R1 RCM's financials
- How volatile are R1 RCM shares?
- Does R1 RCM pay a dividend?
- Other common questions
How has Coronavirus impacted R1 RCM's stock price?
Since the stock market crash in March caused by coronavirus, R1 RCM's stock price has had significant positive movement.
Its last market close was $23.15, which is 39.91% up on its pre-crash value of $13.91 and 225.14% up on the lowest point reached during the March crash when the stocks fell as low as $7.12.
If you had bought $1,000 worth of R1 RCM stocks at the start of February 2020, those stocks would have been worth $694.74 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $1,840.19.
R1 RCM stock priceUse our graph to track the performance of RCM stocks over time.
R1 RCM stocks at a glance
|Latest market close||$23.15|
|52-week range||$13.21 - $31.28|
|50-day moving average||$21.8503|
|200-day moving average||$24.8653|
|Wall St. target price||$33.57|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$0.327|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy R1 RCM stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
R1 RCM price performance over time
|1 month (2021-06-25)||2.21%|
|3 months (2021-04-26)||-14.20%|
Is R1 RCM under- or over-valued?
Valuing R1 RCM stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of R1 RCM's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
R1 RCM's PEG ratio
R1 RCM's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.3902. A low ratio can be interpreted as meaning the stocks offer better value, while a higher ratio can be interpreted as meaning the stocks offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into R1 RCM's future profitability. By accounting for growth, it could also help you if you're comparing the stock prices of multiple high-growth companies.
R1 RCM's EBITDA
R1 RCM's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$223.1 million.
The EBITDA is a measure of a R1 RCM's overall financial performance and is widely used to measure a its profitability.
R1 RCM financials
|Revenue TTM||USD$1.3 billion|
|Operating margin TTM||11.77%|
|Gross profit TTM||USD$249.7 million|
|Return on assets TTM||9.16%|
|Return on equity TTM||45.38%|
|Market capitalisation||USD$5.7 billion|
TTM: trailing 12 months
How to short and sell R1 RCM stocks
- Create a CFD or spread betting account.
- Search for the stock code. E.g. "RCM.US"
- Choose your position size.
- Select "sell" rather than "buy".
- Confirm your position and keep tabs on it. You may wish to set limits on your position.
There are currently 4.8 million R1 RCM stocks held short by investors – that's known as R1 RCM's "short interest". This figure is 3.9% up from 4.7 million last month.
There are a few different ways that this level of interest in shorting R1 RCM stocks can be evaluated.
R1 RCM's "short interest ratio" (SIR)
R1 RCM's "short interest ratio" (SIR) is the quantity of R1 RCM stocks currently shorted divided by the average quantity of R1 RCM stocks traded daily (recently around 1.7 million). R1 RCM's SIR currently stands at 2.79. In other words for every 100,000 R1 RCM stocks traded daily on the market, roughly 2790 stocks are currently held short.
However R1 RCM's short interest can also be evaluated against the total number of R1 RCM stocks, or, against the total number of tradable R1 RCM stocks (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case R1 RCM's short interest could be expressed as 0.02% of the outstanding stocks (for every 100,000 R1 RCM stocks in existence, roughly 20 stocks are currently held short) or 0.0383% of the tradable stocks (for every 100,000 tradable R1 RCM stocks, roughly 38 stocks are currently held short).
Such a low SIR usually points to an optimistic outlook for the stock price, with fewer people currently willing to bet against R1 RCM.
Find out more about how you can short R1 RCM stock.
R1 RCM stock dividends
We're not expecting R1 RCM to pay a dividend over the next 12 months. However, you can browse other dividend-paying stocks in our guide.
R1 RCM stock price volatility
Over the last 12 months, R1 RCM's stocks have ranged in value from as little as $13.21 up to $31.28. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a stocks volatility in relation to the market. The market (NASDAQ average) beta is 1, while R1 RCM's is 0.8172. This would suggest that R1 RCM's stocks are less volatile than average (for this exchange).
R1 RCM overview
R1 RCM Inc. provides revenue cycle management (RCM) for healthcare providers in the United States. The company offers end-to-end RCM services to manage their revenue cycle operations that encompass patient registration, insurance and benefit verification, medical treatment documentation and coding, bill preparation, and collections from patients and payers. It also provides modular services comprising physician advisory services, which assists healthcare organizations in complying with payer requirements regarding whether to classify a hospital visit as an in-patient or an out-patient observation case for billing purposes; practice management services that offers administrative and operational support for patient care and outsource non-core functions; revenue integrity solutions, including charge capture, charge description master maintenance, and pricing services; coding management services, such as business intelligence and analysis, human capital management, accountability framework, and quality management programs; patient experience; and business office services. In addition, the company offers software-as-a-service based scheduling and patient access solutions. It serves healthcare providers, including health systems, hospitals, and physician groups. The company was formerly known as Accretive Health, Inc. and changed its name to R1 RCM Inc. in January 2017. R1 RCM Inc. was incorporated in 2003 and is headquartered in Chicago, Illinois.
Stocks similar to R1 RCM
R1 RCM in the news
ClearBridge Small Cap Strategy Portfolio Manager Commentary Q2 2021
Fly Intel: Top five analyst initiations
BofA starts R1 RCM at Buy, sees 32% upside potential
Frequently asked questions
More guides on Finder
How to buy Zevia PBC (ZVIA) stock in Canada
Everything we know about the Zevia PBC IPO, plus information on how to buy in.
How to buy Xponential Fitness (XPOF) stock in Canada
Everything we know about the Xponential Fitness IPO, plus information on how to buy in.
How to buy SOPHiA Genetics (SOPH) stock in Canada
Everything we know about the SOPHiA Genetics IPO, plus information on how to buy in.
How to buy Ryan Specialty Group Holdings (RYAN) stock in Canada
Everything we know about the Ryan Specialty Group Holdings IPO, plus information on how to buy in.
How to buy Ocean Biomedical (OCEA) stock in Canada when it goes public
Everything we know about the Ocean Biomedical IPO, plus information on how to buy in.
How to buy Instructure Holdings (INST) stock in Canada
Everything we know about the Instructure Holdings IPO, plus information on how to buy in.
How to buy Gambling.com Group (GAMB) stock in Canada
Everything we know about the Gambling.com Group IPO, plus information on how to buy in.
How to buy Elicio Therapeutics (ELTX) stock in Canada when it goes public
Everything we know about the Elicio Therapeutics IPO, plus information on how to buy in.
How to buy Cytek Biosciences (CTKB) stock in Canada
Everything we know about the Cytek Biosciences IPO, plus information on how to buy in.
How to buy Core & Main (CNM) stock in Canada
Everything we know about the Core & Main IPO, plus information on how to buy in.
Ask an Expert
You must be logged in to post a comment.